Asia Pacific Implantable Neurostimulators Market Size & Outlook
Asia Pacific implantable neurostimulators market, 2016-2027 (US$M)
Related Markets
Asia Pacific implantable neurostimulators market highlights
- The Asia Pacific implantable neurostimulators market generated a revenue of USD 704.7 million in 2020.
- The market is expected to grow at a CAGR of 12.9% from 2021 to 2027.
- In terms of segment, spinal cord stimulator was the largest revenue generating type in 2020.
- Sacral Nerve Stimulator is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2021 to 2027.
Asia Pacific data book summary
| Market revenue in 2020 | USD 704.7 million |
| Market revenue in 2027 | USD 1,642.9 million |
| Growth rate | 12.9% (CAGR from 2020 to 2027) |
| Largest segment | Spinal cord stimulator |
| Fastest growing segment | Sacral Nerve Stimulator |
| Historical data covered | 2016 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nevro Corp, LivaNova PLC, NeuroPace Inc, Aleva Neurotherapeutics, Synapse Biomedical |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 13.9% of the global implantable neurostimulators market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2027.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,642.9 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Implantable Neurostimulators Market Scope
Implantable Neurostimulators Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific implantable neurostimulators market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable neurostimulators market will help companies and investors design strategic landscapes.
Spinal cord stimulator was the largest segment with a revenue share of 51.26% in 2020. Horizon Databook has segmented the Asia Pacific implantable neurostimulators market based on spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, gastric electric stimulator covering the revenue growth of each sub-segment from 2016 to 2027.
- Asia Pacific Implantable Neurostimulators Type Outlook (Revenue, USD Million, 2016-2027)
- Spinal Cord Stimulator
- Deep Brain Stimulator
- Sacral Nerve Stimulator
- Vagus Nerve Stimulator
- Gastric Electric Stimulator
- Asia Pacific Implantable Neurostimulators Application Outlook (Revenue, USD Million, 2016-2027)
- Pain Management
- Epilepsy
- Urinary and Fecal Incontinence
- Gastroparesis
- Others
- Parkinson's Disease
Reasons to subscribe to Asia Pacific implantable neurostimulators market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific implantable neurostimulators market databook
-
Our clientele includes a mix of implantable neurostimulators market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific implantable neurostimulators market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific implantable neurostimulators market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific implantable neurostimulators market size, by country, 2016-2027 (US$M)
Asia Pacific Implantable Neurostimulators Market Share, 2020 & 2027 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
